Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Aevi Genomic Medicine Enters into Worldw...||07/15/19|
|Entering Phase 2 clinical trials for the treatment of Lymphatic Malformations which include a number of rare and orphan diseases. PHILADELPHIA, July ...|
|Date||2019-07-25 (BMO)||Est. (EPS/Rev.)||($0.16)/ 0|
|Actual (EPS/Rev.)||/||EPS (TTM)||0|